Blog | CEO views

Our CEO shares his thoughts on the vision that the US recently set out for biotechnology and biomanufacturing and how it aligns wi...

Our CEO explains human cells as biological computers and how this concept will impact healthcare from drug discovery to new therap...

In this blog for the BioIndustry Association, our CEO reflects on the opportunity for UK biotech to drive innovation and growth.

In this blog post for the BioIndustry Association, our CEO reflects on UK Research and Innovation's 2022 strategy.

Our CEO writes about the importance of the synthetic biology industry as part of the UK Life Sciences vision. This was first publi...

Our CEO reflects on a recent UN High-Level Political Forum discussion about industry & academia collaborations to achieve sustaina...

Our CEO explains how our opti-ox technology underpins not only bit.bio but also Meatable - a cultured meat company — and why we ne...